Phase I Study of sss40 Injection for Moderate-to-Severe Bone Metastatic Cancer Pain
Clinical trial NCT07008703 · RECRUITING
Trial details
- NCT number
- NCT07008703
- Sponsor
- Shenyang Sunshine Pharmaceutical Co., LTD.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-27
- Primary completion
- 2025-12-01
- Enrollment
- 132
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.